Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cue Biopharma, Inc. (CUE)  
$1.91 0.27 (12.39%) as of 4:30 Wed 5/8


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 29,500,000
Market Cap: 56.35(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.365 - $4.91
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Cue Biopharma is a biopharmaceutical company engineering a class of injectable biologics to selectively engage and modulate targeted T cells directly within the patient's body. Co. is focusing on drug product candidates for treating cancer in its CUE-100 series, which exploits rationally engineered interleukin 2, in context of the key Immuno- Selective Targeting and Alteration of T Cells framework for selective activation of targeted tumor-specific T cells. Co. is seeking third party support through partnerships and collaborations, or alternative funding structures, to further develop its programs outside of oncology, including its CUE-200, CUE-300 and CUE-400 series.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 7,000 240,000
Total Buy Value $0 $0 $19,620 $836,320
Total People Bought 0 0 2 4
Total Buy Transactions 0 0 2 5
Total Shares Sold 0 0 0 9,325
Total Sell Value $0 $0 $0 $30,586
Total People Sold 0 0 0 1
Total Sell Transactions 0 0 0 1
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 112
  Page 2 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Suri Anish President and CSO   •       –      –    2021-11-11 4 AS $15.07 $301,354 D/D (20,000) 94,038 -67%     
   Suri Anish President and CSO   •       –      –    2021-11-11 4 OE $6.42 $128,400 D/D 20,000 114,038     -
   Suri Anish PRESIDENT AND CSO   •       –      –    2021-10-06 4 D $12.97 $183,318 D/D (14,134) 94,038     -
   Suri Anish PRESIDENT AND CSO   •       –      –    2021-10-03 4 OE $0.00 $0 D/D 33,334 108,172     -
   Millar Kerri-Ann CHIEF FINANCIAL OFFICER   •       –      –    2021-10-01 4 AS $14.21 $17,783 D/D (1,251) 10,472 -57%     
   Millar Kerri-Ann CHIEF FINANCIAL OFFICER   •       –      –    2021-10-01 4 OE $7.50 $9,383 D/D 1,251 11,723     -
   Passeri Daniel R CHIEF EXECUTIVE OFFICER   •       •      –    2021-09-30 4 D $14.57 $461,534 D/D (31,677) 98,700     -
   Passeri Daniel R CHIEF EXECUTIVE OFFICER   •       •      –    2021-09-30 4 OE $0.00 $0 D/D 75,000 130,377     -
   Passeri Daniel R CHIEF EXECUTIVE OFFICER   •       •      –    2021-09-24 4 B $14.72 $50,051 D/D 3,400 55,377 2.81 -53%     
   Suri Anish PRESIDENT AND CSO   •       –      –    2021-09-23 4 AS $15.23 $304,646 D/D (20,000) 74,838 -54%     
   Suri Anish PRESIDENT AND CSO   •       –      –    2021-09-23 4 OE $6.42 $128,400 D/D 20,000 94,838     -
   Millar Kerri-Ann CHIEF FINANCIAL OFFICER   •       –      –    2021-08-23 4 D $0.00 $0 D/D (1,961) 10,472     -
   Millar Kerri-Ann CHIEF FINANCIAL OFFICER   •       –      –    2021-08-23 4 OE $0.00 $0 D/D 6,667 12,433     -
   Pienta Kenneth Chief Medical Officer   •       –      –    2021-03-16 4 AS $15.09 $6,626 D/D (439) 2,000 -29%     
   Pienta Kenneth Chief Medical Officer   •       –      –    2021-03-16 4 OE $5.00 $2,195 D/D 439 2,439     -
   Pienta Kenneth Chief Medical Officer   •       –      –    2021-03-15 4 AS $15.10 $196,269 D/D (13,000) 2,000 -31%     
   Pienta Kenneth Chief Medical Officer   •       –      –    2021-03-15 4 OE $5.00 $65,000 D/D 13,000 15,000     -
   Pienta Kenneth Chief Medical Officer   •       –      –    2021-02-17 4 AS $15.06 $64,345 D/D (4,274) 2,000 -13%     
   Pienta Kenneth Chief Medical Officer   •       –      –    2021-02-17 4 OE $2.86 $18,631 D/D 4,274 6,274     -
   Pienta Kenneth Chief Medical Officer   •       –      –    2021-02-16 4 AS $15.15 $242,422 D/D (16,000) 2,000 -11%     
   Pienta Kenneth Chief Medical Officer   •       –      –    2021-02-16 4 OE $2.86 $45,760 D/D 16,000 18,000     -
   Pienta Kenneth Chief Medical Officer   •       –      –    2021-01-20 4/A AS $15.07 $40,980 D/D (2,720) 2,000     -
   Pienta Kenneth Chief Medical Officer   •       –      –    2021-01-20 4/A OE $2.86 $7,779 D/D 2,720 4,720     -
   Pienta Kenneth Chief Medical Officer   •       –      –    2021-01-20 4 B $15.07 $40,980 D/D 2,720 4,720 2.74 -3%     
   Fletcher Aaron G.l. Director   –       •      –    2020-11-24 4 B $12.64 $82,776 D/D 6,548 165,000 2.39 0%     
  112 Records found
  1  2  3  4  5   
  Page 2 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us